Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells

Breast Cancer Research and Treatment

Volumn 41, Issue 2, 1996, Pages 147-159

  Emerman, Joanne T ^a   Stingl, John ^a   Petersen, Andrea ^a   Shpall, Elizabeth J ^b   Eaves, Connie J ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF COLORADO HOSPITAL   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Bone marrow metastatic infiltrates; Cytokeratins; Epithelial specific antigens; Human breast epithelial cell colonies; Immunocytochemistry; Primary culture

Indexed keywords

KERATIN; KERATIN ANTIBODY;

ARTICLE; BONE MARROW CELL; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL CULTURE; CELL DENSITY; CELL GROWTH; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

BONE MARROW CELLS; BREAST; CELL COUNT; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CYTOLOGICAL TECHNIQUES; EPITHELIAL CELLS; FEMALE; HUMANS; PLEURAL EFFUSION;

EID: 0029844147     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01807160     Document Type: Article

References (39)

1. Bonadonna G: Conceptual and practical advances in the management of breast cancer. J Clin Oncol 7: 1380-1397, 1989
2. Harbeck N, Untch M, Fache L, Eiermann W: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566-571, 1994
3. Antman KH: Dose-intensive therapy in breast cancer. In: Armitage JO, Antman KH (Eds) High-Dose Cancer Therapy. Pharmacology, Hematopoietins, Stem Cells. Williams & Wilkins, Baltimore, Maryland, 1992, pp 701-718
4. Sulkes A: The role of high-dose chemotherapy with autologous bone marrow support in breast cancer: state of the art. Isr J Med Sci 29: 111-116, 1993
5. Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC Jr, Jones J, Shpall E, Wu K, Rosner G, Gilbert C, mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11: 1132-1143, 1993
6. Kennedy MJ, Davis J, Passos-Coelho J, Noga SJ, Huelskamp AM, Ohly K, Davidson NE: Administration of human recombinant granulocyte colony-stimulating factor (Filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer. Cancer Res 53: 5424-5428, 1993
7. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83: 636-640, 1994
8. Dearnaley DP, Ormerod MG, Soane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27: 236-239, 1991
9. Sharp JG, Crouse DA: Marrow contamination: detection and significance. In: Armitage JO, Antman KH (eds) High-Dose Cancer Therapy, Pharmacology, Hematopoietins, Stem Cells. Williams and Wilkins, Baltimore, 1992, pp 226-248
10. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82: 2605-2610, 1993
11. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991
12. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27: 1552-1555, 1991
13. Courtenay VD, Mills J: In vitro colony assay for human tumours grown in immunosuppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37: 261-268, 1978
14. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321-1327, 1978
15. Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR: Clonal proliferation of cultured non-malignant and malignant human breast epithelia. Cancer Res 41: 4637-4643, 1981
16. Cillo C, Odartchenko N: Cloning of human tumor cells in methylcelluluse-containing medium. In: Predictive Drug Testing on Human Tumor Cells. Springer, Berlin, Heidelberg, New York, 1984, pp 56-64
17. Ethier SP, Mahacek ML, Gullick WJ, Krank TS, Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 53: 627-635, 1993
18. Emerman JT, Wilkinson DA: Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples. In Vitro Cell Dev Biol 26: 1186-1194, 1990
19. Lemoine FM, Humphries RK, Abraham SDM, Krystal G, Eaves CJ: Partial characterization of a novel stromal cell-derived pre-B-cell growth factor active on normal and immortalized pre-B cells. Exp Hematol 16: 718-726, 1988
20. Eaves CJ, Cashman JD, Eaves AC: Methodology of long-term culture of human hemopoietic cells. J Tiss Cult Meth 13: 55-62, 1991
21. Emerman JT, Eaves CJ: Lack of effect of hematopoietic growth factors on human breast epithelial cell growth in serum-free primary culture. Bone Marrow Transplant 13: 285-291, 1994
22. Pinkus GS, O'Connor EM, Etheridge CL, Corson JM: Optimal immunoreactivity of keratin proteins in formalin-fixed, paraffin-embedded tissue requires preliminary trypsinization. J Histochem Cytochem 33: 465-473, 1985
23. Latza V, Niedobitek G, Schwarting G, Nekarda H, Stein H: Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43: 213-219, 1990
24. r 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47: 2883-2891, 1987
25. Asch BB, Asch HL: Structural components as markers of differentiation and neoplastic progression in mammary epithelial cells. In: Cellular and Molecular Biology of Mammary Cancer. Plenum Press, New York, 1987, pp 29-45
26. Johnston CS, Shpall EJ, Williams S, Hami L, Jones RB, Bast RC, Ceriani RL, Franklin W: Detection of minimal residual breast cancer in bone marrow. In: Advances in Bone Marrow Purging and Processing. Wiley-Liss, 1992, pp 637-642
27. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91: 12223-12227, 1994
28. Gabelman BM, Emerman JT: Effects of estrogen, epidermal growth factor, and transforming growth factor-α on the growth of human breast epithelial cells in primary culture. Exp Cell Res 201: 113-118, 1992
29. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78: 666-672, 1991
30. Smith HS, Zoli W, Volpi A, Hiller A, Lippman M, Swain S, Mayall B, Dollbaum C, Hackett AJ, Amadori D: Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells. Cancer Res 50: 2943-2948, 1990
31. Zoli W, Volpi A, Bonaguri C, Riccobon A, Savini S, Brizio R, Saragoni A, Medri L, Marra GA, Amadori D: An efficient method of culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: Experience in 136 primary cancers and on 116 recurrences. Breast Cancer Res Treat 17: 231-238, 1990
32. Bergstraesser LM, Weitzman SA: Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res 53: 2644-2654, 1993
33. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ: Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89: 9064-9068, 1992
34. Steel GG: Growth kinetics of tumors: Cell proliferation kinetics in relation to the growth and treatment of cancer. In: Anonymous Oxford Clarendon Press, 1977
35. Joshi SS, Novak DJ, Messbarger L, Maitreyan V, Weisenburger DD, Sharp JG: Levels of detection of tumor cells in human bone marrow with or without prior culture. Bone Marrow Transplant 6: 179-183, 1990
36. Band V, Sager R: Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86: 1249-1253, 1989
37. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: Relation to in vivo phenotypes and influence of medium. J Cell Sci 94: 403-413, 1989
38. Hall L, Henney A, Ralphs DNL, Herries DG, Craig RK: Changes in gene expression in established human mammary tumor cell lines when compared with normal breast and breast tumor tissue. Cancer Res 46: 5786-5794, 1986
39. Sharp JG, Armitage J, Crouse D, Joshi S, Kessinger A, Mann S, Vaughan W, Weisenburger D: Recent progress in the detection of metastatic tumor in bone marrow by culture techniques. In: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ (eds) Autologous Bone Marrow Transplantation. Proceedings of the Fourth International Symposium, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 1989, pp 421-425